Company news
OPKO Health, Inc. news in 2024
OPKO Health, Inc.'s news releases, calls and decks from 2024, newest first.
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 19, 2024
OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results
November 6, 2024
OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024
October 28, 2024
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
October 6, 2024
Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
September 24, 2024
OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
September 22, 2024
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health
September 15, 2024
OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results
August 6, 2024
OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024
July 31, 2024
OPKO Health Announces $100 Million Share Repurchase Program
July 17, 2024
OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments
July 16, 2024
OPKO Health to Participate in the Jefferies Global Healthcare Conference
May 30, 2024
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
May 6, 2024
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
May 2, 2024
OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results
February 26, 2024
OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024
February 21, 2024
OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes
January 8, 2024
OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 7, 2024
OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029
January 3, 2024
OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029
January 2, 2024
Calls in 2024
Decks in 2024
- Investor Presentation (March 2024)
Investor deck · 26 slides · Mar 28, 2024
- Investor Presentation (March 2024)
Investor deck · 23 slides · Mar 28, 2024
- Investor Presentation (January 2024)
Investor deck · 26 slides · Jan 4, 2024